648
Participants
Start Date
March 12, 2024
Primary Completion Date
June 11, 2025
Study Completion Date
June 11, 2025
RSVpreF vaccine
RSVpreF vaccine
Placebp
Placebo
REIMED Reiger Park, Boksburg
Worthwhile Clinical Trials, Benoni
Wits RHI, Johannesburg
University of Witwatersrand (WITS) - Vaccines and Infectious Diseases Analytics (VIDA), Johannesburg
Wits VIDA Nkanyezi Research Unit, Johannesburg
Qhakaza Mbokodo Research Clinic, Ladysmith
Synergy Biomed Research Institute, East London
FAMCRU - Worcester, Worcester
MRC Unit on Child And Adolescent Health, Cape Town
Gugulethu Green Clinic, Cape Town
Josha Research, Bloemfontein
Setshaba Research Centre, Pretoria
Botho Ke Bontle Health Services, Pretoria
Gole Biomed Research Centre, Polokwane
Lead Sponsor
Pfizer
INDUSTRY